新型冠状病毒肺炎流行现状及应对策略进展  

Current status of COVID-19 pandemic and progress in response strategy

作　　者：高文静[1] 王波 吕筠[1] 余灿清[1] 王岚[3] 李立明[1] Gao Wenjing;Wang Bo;Lyu Jun;Yu Canqing;Wang Lan;Li Liming(School of Public Health,Peking University/Peking University Center for Public Health and Epidemic Preparedness&Response,Beijing 100191,China;Meinian Public Health Institute,Peking University Health Science Center,Beijing 100191,China;National Institute for Communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China)

机构地区：[1]北京大学公共卫生学院/北京大学公众健康与重大疫情防控战略研究中心,100191 [2]北京大学医学部美年公众健康研究院,100191 [3]中国疾病预防控制中心传染病预防控制所,北京102206

出　　处：《中华流行病学杂志》2021年第1期22-27,共6页Chinese Journal of Epidemiology

基　　金：国家自然科学基金(82041027)。

摘　　要：随着北半球秋冬季节来临,以呼吸道飞沫和密切接触传播为主要途径的新型冠状病毒肺炎(新冠肺炎,2019冠状病毒病)给各国防控带来了新的挑战。本文从新冠病毒变异、全球流行形势、群体免疫问题、无症状感染对我国疫情防控的影响、疫苗的进展和治疗等方面对新冠肺炎流行及应对现状进行综述,以期为新形势下我国疫情防控策略的规划和调整提供借鉴。As the approaching of autumn and winter in northern hemisphere,COVID-19,mainly transmitted through respiratory droplets and close contact,has posed new challenge to the countries across the world.This paper summarizes the current status of COVID-19 pandemic and related responses performed in terms of the variation of SARS-CoV-2,global situation reports,herd immunity and the influence of asymptomatic infection on COVID-19 prevention and control in China,as well as vaccine development progress and case treatment for the purpose of providing reference to further improve the COVID-19 prevention and control strategy in China.

关 键 词：新型冠状病毒肺炎 无症状感染者 群体免疫 疫苗 疾病管理 

分 类 号：R563.1[医药卫生—呼吸系统] R181.8[医药卫生—内科学]